PT76166B - Process for the preparation of nasal pharmaceutical compositions containing dihydroergotamine and cafeine - Google Patents

Process for the preparation of nasal pharmaceutical compositions containing dihydroergotamine and cafeine

Info

Publication number
PT76166B
PT76166B PT76166A PT7616683A PT76166B PT 76166 B PT76166 B PT 76166B PT 76166 A PT76166 A PT 76166A PT 7616683 A PT7616683 A PT 7616683A PT 76166 B PT76166 B PT 76166B
Authority
PT
Portugal
Prior art keywords
cafeine
preparation
pharmaceutical compositions
compositions containing
nasal pharmaceutical
Prior art date
Application number
PT76166A
Other languages
English (en)
Portuguese (pt)
Other versions
PT76166A (en
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of PT76166A publication Critical patent/PT76166A/pt
Publication of PT76166B publication Critical patent/PT76166B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT76166A 1982-02-01 1983-01-31 Process for the preparation of nasal pharmaceutical compositions containing dihydroergotamine and cafeine PT76166B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01

Publications (2)

Publication Number Publication Date
PT76166A PT76166A (en) 1983-02-01
PT76166B true PT76166B (en) 1986-02-04

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
PT76166A PT76166B (en) 1982-02-01 1983-01-31 Process for the preparation of nasal pharmaceutical compositions containing dihydroergotamine and cafeine

Country Status (27)

Country Link
JP (1) JPS58134017A (US20100268047A1-20101021-C00004.png)
AT (1) AT385656B (US20100268047A1-20101021-C00004.png)
AU (1) AU565613B2 (US20100268047A1-20101021-C00004.png)
BE (1) BE895750A (US20100268047A1-20101021-C00004.png)
CA (1) CA1197783A (US20100268047A1-20101021-C00004.png)
CH (1) CH653555A5 (US20100268047A1-20101021-C00004.png)
DE (1) DE3302949A1 (US20100268047A1-20101021-C00004.png)
DK (1) DK164771C (US20100268047A1-20101021-C00004.png)
ES (1) ES8502865A1 (US20100268047A1-20101021-C00004.png)
FI (1) FI81258C (US20100268047A1-20101021-C00004.png)
FR (1) FR2539994B1 (US20100268047A1-20101021-C00004.png)
GR (1) GR81320B (US20100268047A1-20101021-C00004.png)
HK (1) HK59989A (US20100268047A1-20101021-C00004.png)
HU (1) HU191512B (US20100268047A1-20101021-C00004.png)
IE (1) IE54532B1 (US20100268047A1-20101021-C00004.png)
IL (1) IL67822A (US20100268047A1-20101021-C00004.png)
IT (1) IT1197558B (US20100268047A1-20101021-C00004.png)
KE (1) KE3888A (US20100268047A1-20101021-C00004.png)
LU (1) LU84613A1 (US20100268047A1-20101021-C00004.png)
MY (1) MY8700766A (US20100268047A1-20101021-C00004.png)
NL (1) NL192325C (US20100268047A1-20101021-C00004.png)
NZ (1) NZ203117A (US20100268047A1-20101021-C00004.png)
PH (1) PH22198A (US20100268047A1-20101021-C00004.png)
PT (1) PT76166B (US20100268047A1-20101021-C00004.png)
SE (1) SE454402B (US20100268047A1-20101021-C00004.png)
SG (1) SG34389G (US20100268047A1-20101021-C00004.png)
ZA (1) ZA83673B (US20100268047A1-20101021-C00004.png)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
JP7317020B2 (ja) * 2018-01-05 2023-07-28 インペル ファーマシューティカルズ インコーポレイテッド 精密嗅覚デバイスによるジヒドロエルゴタミンの鼻腔内送達

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
FR2387035A1 (fr) * 1977-04-12 1978-11-10 Cassenne Lab Sa Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux
DE2831728C2 (de) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Arzneimittel zur Behandlung von Kopfschmerzen

Also Published As

Publication number Publication date
SE454402B (sv) 1988-05-02
ATA30383A (de) 1987-10-15
DE3302949A1 (de) 1983-08-11
FR2539994B1 (fr) 1986-10-10
HK59989A (en) 1989-08-04
SG34389G (en) 1989-09-22
FI81258B (fi) 1990-06-29
FI81258C (fi) 1990-10-10
NL192325C (nl) 1997-06-04
CA1197783A (en) 1985-12-10
BE895750A (fr) 1983-08-01
ZA83673B (en) 1984-09-26
IE830187L (en) 1983-08-01
AT385656B (de) 1988-05-10
NL192325B (nl) 1997-02-03
IT1197558B (it) 1988-12-06
IL67822A (en) 1988-02-29
JPH0253406B2 (US20100268047A1-20101021-C00004.png) 1990-11-16
SE8300495L (sv) 1983-08-02
GR81320B (US20100268047A1-20101021-C00004.png) 1984-12-11
PT76166A (en) 1983-02-01
DE3302949C2 (US20100268047A1-20101021-C00004.png) 1992-05-21
DK38183D0 (da) 1983-01-31
HU191512B (en) 1987-02-27
FR2539994A1 (fr) 1984-08-03
LU84613A1 (fr) 1983-09-08
AU1085083A (en) 1983-08-11
AU565613B2 (en) 1987-09-24
MY8700766A (en) 1987-12-31
ES519450A0 (es) 1985-02-01
IL67822A0 (en) 1983-06-15
NZ203117A (en) 1986-12-05
FI830245A0 (fi) 1983-01-25
JPS58134017A (ja) 1983-08-10
IE54532B1 (en) 1989-11-08
ES8502865A1 (es) 1985-02-01
DK164771B (da) 1992-08-17
CH653555A5 (de) 1986-01-15
IT8347646A0 (it) 1983-02-01
PH22198A (en) 1988-06-28
KE3888A (en) 1989-09-01
DK164771C (da) 1992-12-28
NL8300325A (nl) 1983-09-01
DK38183A (da) 1983-08-02
FI830245L (fi) 1983-08-02
SE8300495D0 (sv) 1983-01-31

Similar Documents

Publication Publication Date Title
PT81746A (en) Process for the preparation of peptide-aldehydes and of pharmaceutical compositions containing them
PT77173A (en) Process for preparing novel phenethanolamines and of pharmaceutical compositions containing the same
PT77281A (en) Process for preparing n-formyl and n-hydroxymethyl-3-phenoxy-1-azetidinecarboxamides and of pharmaceutical compositions containing the same
PT76809A (en) Process for preparing 1-sulfo-2-oxoazetidine derivatives and of pharmaceutical compositions containing the same
PT78570A (en) Process for preparing 1-pyriminyloxy-3-hetarylalkylamino-2-propanols and of pharmaceutical compositions containing the same
PT76523B (en) Process for preparing phenoxyalkylcarboxylic acid derivatives and of pharmaceutical compositions containing the same
GB2167746B (en) A process for the preparation of isosilybin-free silibinin and pharmaceutical compositions containing it
PT76657A (en) Process for preparing 4-aryl-4-piperidinecarbinols and of pharmaceutical compositions containing the same
PT77217A (en) Process for preparing 3-phenoxy-1-azetidine-carboxamides and of pharmaceutical compositions containing the same
PT80794A (en) Process for the preparation of novel isoindolinyl-alkyl-piperazines and of pharmaceutical compositions containing the same
PT79858A (en) Process for the preparation of azolyl-aryl-alcanol and pharmaceutical compositions therewith
PT75042B (en) Process for the preparation of apovincaminates and pharmaceutical compositions containing them
PT80824A (en) Process for the preparation of phenylquinoline derivatives and of pharmaceutical compositions containing the same
PT76870B (en) Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them
PT76658A (en) Process for preparing quinazoline derivatives and of pharmaceutical compositions containing the same
PT75265A (en) Process for the preparation of diazabicyclicononanes substituted and pharmaceutical composition containing them
PT81083A (en) Process for the preparation of substituted 7-oxomitosanes and of pharmaceutical compositions containing the same
PT76166B (en) Process for the preparation of nasal pharmaceutical compositions containing dihydroergotamine and cafeine
PT76426A (en) Process for preparing novel 2-beta-d-ribofuranosylselenazole-4-carboxamide compounds and of pharmaceutical compositions containing the same
PT77282B (en) Process for preparing substituted 1-pyridyloxy-3-indolylalkylamino-2-propanols and of pharmaceutical compositions containing the same
PT74400A (en) Process for the preparation of 17,18-dehydro-apovincaminol-3', 4',5'-trimethoxy-benzoate and of pharmaceutical compositions containing them
PT77730B (en) Process for preparing acridanone derivatives and of pharmaceutical compositions containing the same
PT76953A (en) Process for the preparation of eburnane oxime ethers and pharmaceutical compositions containing them
PT79990B (en) Process for the preparation of diazepine-indoles and of pharmaceutical compositions therewith
PT82118A (en) Process for the preparation of 3-aryloxyazetidinecarboxamides and of pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
PC3A Transfer or assignment

Free format text: 971017 NOVARTIS AG CH